Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Defense was posted on September 10, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Japanese Encephalitis Vaccine (JEV)

Closed
SPE2DP-19-R-0112(A)Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

19 days ago

DEADLINE

in 21 days

General Info

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

PA

Set-Aside

NONE

Documents

2

final+solicitation+JEV.pdf

PDF

SF30_SPE2DP19R01120001.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

8 updates
PhaseClosed
Posted

Presolicitation

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Deadline changed

Response deadline added: Oct 12, 2020.

Notice updated

Notice details unchanged. Attachments may have changed.

Deadline changed

Response deadline changed from Oct 12, 2020 to Sep 10, 2020.

Notice updated

Notice details unchanged. Attachments may have changed.

Deadline changed

Response deadline time changed from 7:00 PM UTC to 5:15 PM UTC on Sep 10, 2020.

Notice updated

Notice details unchanged. Attachments may have changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts1 person available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA
Contacts

Full Description

Show more
The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Vaccine (JEV), NSN 6505-01-607-7018. The vaccine shall be purified, inactivated, Vero Cell culture derived, contain no stabilizers, Thimerosal/Preservative free, Latex free, licensed by the Food and Drug Administration (FDA), suitable for intramuscular administration and intended for active immunization against Japanese Encephalitis disease. The vaccine shall be a sterile 0.5 ml suspension in a pre-filled syringe (Type 1 glass) with a plunger stopper (chlorobutyl elastomer) with or without a separate needle. The vaccine must be approved by the United States FDA for administration to persons 2 months and up. The proposed contract will be a one (1) year base and two (2) one-year options firm-fixed price indefinite quantity contract. The requirement for the base year is 370,000 doses minimum and a maximum of 420,000 doses, 320,000 doses minimum and 400,000 doses maximum for option year 1, and 250,000 doses minimum and 330,000 doses maximum for option year 2. Ordered quantities shall be delivered to the Defense Distribution Depot Susquehanna. Delivery is to be FOB Destination and delivered within 120 days from date of the delivery order. All responsible sources may submit a proposal and shall be considered by the Agency. The successful contractor shall have FDA approval to sell JEV before award of the contract. Solicitation SPE2DP-19-R-0112 is expected to be issued on or after December 11, 2019 and can be found on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. The point of contact is Danielle Delaney, DLA Troop Support-FSA, 215-737-2998. The Solicitation will be issued under authority 10 U.S.C. 2034 (c) 1, only one responsible source.

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS